Insider Transactions in Q1 2017 at Abbott Laboratories (ABT)
Insider Transaction List (Q1 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2017
|
Joseph J Manning EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
287
-1.39%
|
$12,628
$44.69 P/Share
|
|
Feb 20
2017
|
Jared Watkin SENIOR VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-1.37%
|
$32,560
$44.69 P/Share
|
|
Feb 20
2017
|
Andrew H Lane EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
605
-3.83%
|
$26,620
$44.69 P/Share
|
|
Feb 17
2017
|
Eric S Fain Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
23,085
+4.07%
|
-
|
|
Feb 17
2017
|
Jaime Contreras Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
19,961
+22.79%
|
-
|
|
Feb 17
2017
|
Stephen R Fussell Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
26,351
+11.98%
|
-
|
|
Feb 17
2017
|
Robert B Ford CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
21,959
+23.01%
|
-
|
|
Feb 17
2017
|
Deepak S. Nath Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,089
+15.94%
|
-
|
|
Feb 17
2017
|
Heather L Mason Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
5,630
+7.43%
|
-
|
|
Feb 17
2017
|
Jared Watkin SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
7,393
+12.05%
|
-
|
|
Feb 17
2017
|
John M Capek EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
14,273
+4.71%
|
-
|
|
Feb 17
2017
|
Roger Bird SENIOR VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
13,307
+17.23%
|
-
|
|
Feb 17
2017
|
Funck, Jr. Robert E. EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+7.12%
|
-
|
|
Feb 17
2017
|
Brian B Yoor Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,763
+22.17%
|
-
|
|
Feb 17
2017
|
Miles D White EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
92,342
+2.8%
|
-
|
|
Feb 17
2017
|
Hubert L Allen EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
24,155
+17.66%
|
-
|
|
Feb 17
2017
|
Daniel Gesua Sive Salvadori EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
19,961
+20.18%
|
-
|
|
Feb 17
2017
|
Brian J Blaser Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
26,351
+13.32%
|
-
|
|
Feb 13
2017
|
Hubert L Allen EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,400
-3.7%
|
$146,200
$43.0 P/Share
|
|
Feb 13
2017
|
Hubert L Allen EXECUTIVE VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,400
+3.57%
|
$85,000
$25.25 P/Share
|
|
Feb 03
2017
|
Joseph J Manning EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
213
-1.02%
|
$8,946
$42.75 P/Share
|
|
Feb 03
2017
|
Joseph J Manning EXECUTIVE VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+1.42%
|
$7,500
$25.25 P/Share
|
|
Jan 31
2017
|
Heather L Mason Executive Vice President |
SELL
Open market or private sale
|
Direct |
35,700
-35.63%
|
$1,428,000
$40.77 P/Share
|
|
Jan 31
2017
|
Heather L Mason Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,700
+26.27%
|
$892,500
$25.25 P/Share
|
|
Jan 31
2017
|
Stephen R Fussell Executive Vice President |
BUY
Open market or private purchase
|
Direct |
12,200
+6.8%
|
$488,000
$40.77 P/Share
|
|
Jan 04
2017
|
Michael J Warmuth Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.04%
|
-
|
|
Jan 04
2017
|
Eric S Fain Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
519,467
+26.84%
|
-
|
|
Jan 04
2017
|
Michael T Rousseau Pres., Cardiovas. & Neuromod. |
BUY
Grant, award, or other acquisition
|
Indirect |
446,178
+24.08%
|
-
|
|
Jan 04
2017
|
Michael T Rousseau Pres., Cardiovas. & Neuromod. |
BUY
Grant, award, or other acquisition
|
Direct |
186,404
+39.56%
|
-
|